Bone Marrow Transplantation - Table of Contents alert Volume 52 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 52, Issue 8 (August 2017) In this issue Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement We are pleased to announce that the Impact Factor* for Bone Marrow Transplantation is now 3.874 - an increase from 3.636 last year. Bone Marrow Transplantation is ranked 7 of 25 in the Transplantation category, 20 of 70 in the Hematology category, 71 of 217 Oncology category and 47 of 150 in the Immunology category. The journal would like to thank all our authors, reviewers and readers for their continued support. *2016 Journal Citation Reports (Clarivate Analytics, 2017) Submit your research >>>     Reviews Top Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy B Gyurkocza, H M Lazarus and S Giralt Bone Marrow Transplant 2017 52: 1083-1090; advance online publication, February 27, 2017; 10.1038/bmt.2017.8 Abstract | Full Text Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis C E Dandoy, M I Ardura, G A Papanicolaou and J J Auletta Bone Marrow Transplant 2017 52: 1091-1106; advance online publication, March 27, 2017; 10.1038/bmt.2017.14 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes R Martino, A Henseler, M van Lint, N Schaap, J Finke, D Beelen, S Vigouroux, E P Alessandrino, G J Mufti, J H Veelken, B Bruno, I Yakoub-Agha, L Volin, J Maertens, R Or, V Leblond, M Rovira, P Kalhs, A F Alvarez, A Vitek, J Sierra, E Wagner, M Robin, T de Witte and N Kröger for the Myelodysplastic Syndrome subcommittee of the Chronic Malignancies Working Party of the European Blood and Marrow Transplantation Group Bone Marrow Transplant 2017 52: 1107-1112; advance online publication, March 20, 2017; 10.1038/bmt.2017.19 Abstract | Full Text LYMPHOMA High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study E Schorb, C P Fox, K Fritsch, L Isbell, A Neubauer, A Tzalavras, R Witherall, S Choquet, O Kuittinen, D De-Silva, K Cwynarski, C Houillier, K Hoang-Xuan, V Touitou, N Cassoux, J-P Marolleau, J Tamburini, R Houot, V Delwail, G Illerhaus, C Soussain and B Kasenda Bone Marrow Transplant 2017 52: 1113-1119; advance online publication, April 24, 2017; 10.1038/bmt.2017.23 Abstract | Full Text Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party L Bento, A Boumendil, H Finel, S Le Gouill, S Amorim, H Monjanel, R Bouabdallah, J O Bay, E Nicolas-Virelizier, G McQuaker, G Rossi, R Johnson, A Huynh, P Ceballos, A Rambaldi, E Bachy, R Malladi, K Orchard, D Pohlreich, H Tilly, F Bonifazi, X Poiré, F Guilhot, A Haenel, C Crawley, B Metzner, J Gribben, N H Russell, G Damaj, K Thomson, P Dreger and S Montoto on behalf of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2017 52: 1120-1125; advance online publication, May 22, 2017; 10.1038/bmt.2017.88 Abstract | Full Text PLASMA CELL DISORDERS Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival N Tandon, E Muchtar, S Sidana, A Dispenzieri, M Q Lacy, D Dingli, F K Buadi, S R Hayman, R Chakraborty, W J Hogan, W Gonsalves, R Warsame, T V Kourelis, N Leung, P Kapoor, S K Kumar and M A Gertz Bone Marrow Transplant 2017 52: 1126-1132; advance online publication, April 10, 2017; 10.1038/bmt.2017.68 Abstract | Full Text AUTOIMMUNE DISORDERS Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) J Burman, K Kirgizov, K Carlson, M Badoglio, G L Mancardi, G De Luca, B Casanova, J Ouyang, R Bembeeva, J Haas, P Bader, J Snowden and D Farge Bone Marrow Transplant 2017 52: 1133-1137; advance online publication, March 20, 2017; 10.1038/bmt.2017.40 Abstract | Full Text GRAFT SOURCE Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML M Kwon, G Bautista, P Balsalobre, I Sánchez-Ortega, P Montesinos, A Bermúdez, A de Laiglesia, P Herrera, C Martin, K Humala, A Zabalza, M Torres, L Bento, L L Corral, I Heras, D Serrano, I Buño, J Anguita, C Regidor, R Duarte, R Cabrera, J Gayoso and J L Diez-Martin on behalf of Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH) Bone Marrow Transplant 2017 52: 1138-1143; advance online publication, March 27, 2017; 10.1038/bmt.2017.36 Abstract | Full Text HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES Partial break in tolerance of NKG2A−/LIR-1− single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation S Rathmann, C Keck, C Kreutz, N Weit, M Müller, J Timmer, S Glatzel, M Follo, M Malkovsky, M Werner, R Handgretinger, J Finke and P Fisch Bone Marrow Transplant 2017 52: 1144-1155; advance online publication, May 8, 2017; 10.1038/bmt.2017.81 Abstract | Full Text TRANSPLANT TOXICITIES Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation A Kawajiri, S Fuji, Y Tanaka, C Kono, T Hirakawa, T Tanaka, R Ito, Y Inoue, K Okinaka, S Kurosawa, Y Inamoto, S-W Kim, T Yamashita and T Fukuda Bone Marrow Transplant 2017 52: 1156-1163; advance online publication, March 20, 2017; 10.1038/bmt.2017.27 Abstract | Full Text Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation N Kawashima, S Terakura, S Nishiwaki, D Koyama, Y Ozawa, M Ito and K Miyamura Bone Marrow Transplant 2017 52: 1164-1170; advance online publication, April 3, 2017; 10.1038/bmt.2017.58 Abstract | Full Text The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults S J Rotz, T D Ryan, S Jodele, J L Jefferies, A Lane, A Pate, R Hirsch, J Hlavaty, A E Levesque, M D Taylor, M Cash, K C Myers, J A El-Bietar, S M Davies and C E Dandoy Bone Marrow Transplant 2017 52: 1171-1179; advance online publication, April 10, 2017; 10.1038/bmt.2017.62 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease R S Mehta, Q Cao, S Holtan, M L MacMillan and D J Weisdorf Bone Marrow Transplant 2017 52: 1180-1186; advance online publication, May 15, 2017; 10.1038/bmt.2017.90 Abstract | Full Text Letters to the Editor Top Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant R Salem, R Massoud, B Haffar, R Mahfouz, A Bazarbachi and J El-Cheikh Bone Marrow Transplant 2017 52: 1187-1190; advance online publication, June 5, 2017; 10.1038/bmt.2017.82 Full Text Preoperative autologous blood donation in healthy bone marrow donors contributes to pre-procedure anemia S P Manuel, T R Spitzer and Y Ishizawa Bone Marrow Transplant 2017 52: 1191-1193; advance online publication, May 22, 2017; 10.1038/bmt.2017.84 Full Text Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial OPEN S Huhn, N Weinhold, J Nickel, M Pritsch, T Hielscher, M Hummel, U Bertsch, B Huegle-Doerr, M Vogel, R Angermund, M Hänel, H J Salwender, K Weisel, J Dürig, M Görner, H Kirchner, N Peter, U Graeven, F Lordick, M Hoffmann, P Reimer, I W Blau, A Jauch, K Dembowsky, T Möhler, P Wuchter and H Goldschmidt Bone Marrow Transplant 2017 52: 1194-1198; advance online publication, May 15, 2017; 10.1038/bmt.2017.91 Full Text Transfusion practices for bone marrow harvests: a survey analysis from the AABB Bone Marrow Quality Improvement Initiative Working Group T R Spitzer, M W Sugrue, C Gonzalez, P O'Donnell, D Confer, E Fuchs, M A Pulsipher, J Schwartz and M Linenberger Bone Marrow Transplant 2017 52: 1199-1200; advance online publication, May 22, 2017; 10.1038/bmt.2017.92 Full Text Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection A Ohmoto, S Fuji, A Miyagi-Maeshima, S-W Kim, K Tajima, T Tanaka, K Okinaka, S Kurosawa, Y Inamoto, H Taniguchi and T Fukuda Bone Marrow Transplant 2017 52: 1201-1203; advance online publication, May 15, 2017; 10.1038/bmt.2017.93 Full Text Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide A Unnikrishnan, S C Glover, O Norkina, J R Wingard and M Norkin Bone Marrow Transplant 2017 52: 1204-1205; advance online publication, June 5, 2017; 10.1038/bmt.2017.94 Full Text Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients OPEN M Espiño, A Arteche-López, S Medina, C Muñoz-Calleja, M J Blanchard, A Alegre, F J López-Jiménez and L M Villar Bone Marrow Transplant 2017 52: 1206-1207; advance online publication, June 5, 2017; 10.1038/bmt.2017.97 Full Text Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma L Giaccone, M Festuccia, F Zallio, R Sorasio, L Brunello, E Maffini, C Dellacasa, R Passera, G Iovino, S Aydin, M Boccadoro, U Vitolo, N Mordini, M Pini, A Busca and B Bruno Bone Marrow Transplant 2017 52: 1208-1211; advance online publication, June 5, 2017; 10.1038/bmt.2017.99 Full Text The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest C Chabannon, F Bijou, J-M Grouin, P Drillat, N Milpied and M Mohty Bone Marrow Transplant 2017 52: 1212-1214; advance online publication, June 5, 2017; 10.1038/bmt.2017.103 Full Text Prospective computerized monitoring of cognitive functioning before and after blood and marrow transplantation K L Votruba, F Hoodin, B Giordani, R Kentor, D R Couriel and C L Kitko Bone Marrow Transplant 2017 52: 1215-1217; advance online publication, June 12, 2017; 10.1038/bmt.2017.105 Full Text Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database A Necchi, S Lo Vullo, G Rosti, M Badoglio, P Giannatempo, D Raggi, S Secondino, L Mariani, F Lanza and P Pedrazzoli on behalf of the European Society for Blood and Marrow Transplantation, Solid Tumors Working Party (EBMT-STWP) Bone Marrow Transplant 2017 52: 1218-1220; advance online publication, June 5, 2017; 10.1038/bmt.2017.106 Full Text MRD response in a refractory paediatric T-ALL patient through anti-programmed cell death 1 (PD-1) Ab treatment associated with induction of fatal GvHD A-M Boekstegers, F Blaeschke, I Schmid, V Wiebking, S Immler, F Hoffmann, K Bochmann, S Müller, T G P Grünewald, J Feucht and T Feuchtinger Bone Marrow Transplant 2017 52: 1221-1224; advance online publication, June 5, 2017; 10.1038/bmt.2017.107 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.